Boehringer Ingelheim Builds Lab for Digital HealthcareBy
Boehringer Ingelheim has formed BI X as an independent subsidiary to focus on digital solutions in healthcare from idea to pilot. The start-up will work closely together with all three business units of the company: human pharma, animal health, and biopharmaceuticals. It will provide a platform for collaborating with specialists in the field of data science, software development, and user-experience design.
BI X will develop prototypes for new products and solutions and test them together with the company’s business units in pilot phases. The business units will then use the successfully developed new products and solutions themselves and bring them to the market. This approach is to ensure that knowledge and experience accrued at BI X are being integrated into the digital lab’s parent house.
BI X will serve as a digital lab for its parent house, taking up operations in July 2017. Boehringer Ingelheim is set to invest EUR10 million ($11.2 million) in BI X in 2017 and has started to recruit globally a multidiscipline team of 50 specialists. The digital lab will be located in Ingelheim at the company’s headquarters in Germany.
Source: Boehringer Ingelheim